Trials / Completed
CompletedNCT01684020
A Study Evaluating the Efficacy and Safety of ARTISS Human Fibrin Sealant as Used in External Rhinoplasty
A Prospective, Double-Blinded, Randomized Study Evaluating the Efficacy and Safety of ARTISS Human Fibrin Sealant as Used in External Rhinoplasty
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- DeNova Research · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Rhinoplasty (nasal reconstruction i.e. "a nose job") is a surgical procedure performed on the nose to correct a medical problem or change the appearance of the nose. During the healing process, swelling and/or bruising is likely to occur. A drug called ARTISS Fibrin Sealant may or may not lessen these effects. This study is looking to see the effects of ARTISS on adhering tissue and improving wound healing in an external rhinoplasty. The purpose of this study is to evaluate the safety and effectiveness of rhinoplasty using ARTISS compared to rhinoplasty without using ARTISS in patients undergoing rhinoplasty performed through an external approach.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ARTISS human fibrin sealant |
Timeline
- Start date
- 2012-11-28
- Primary completion
- 2016-04-26
- Completion
- 2016-04-26
- First posted
- 2012-09-12
- Last updated
- 2020-11-02
- Results posted
- 2020-10-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01684020. Inclusion in this directory is not an endorsement.